✦ LIBER ✦

Intraabdominal pressure in liver transplant recipients: incidence and clinical significance

✍ Scribed by G Biancofiore; M.L Bindi; A Boldrini; G Consani; M Bisà; M Esposito; L Urbani; G Catalano; F Filipponi; F Mosca

Book ID: 116929703
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 60 KB
Volume: 36
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2004.02.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Significance of Surveillance Cu

Clinical Significance of Surveillance Culture in Liver Transplant Recipients

✍ Kim, Y.J.; Kim, S.I.; Jun, Y.H.; Choi, J.Y.; Yoon, S.K.; You, Y.-K.; Kim, D.-G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Clinical significance of donor-specific

Clinical significance of donor-specific alloantibodies in liver transplant recipients

✍ H. Rodrigues; F. Monteiro; P. Massarolo; C. Viggiani; G. Preuhs; N. Panajotopoul 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Incidence and clinical significance of h

Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients

✍ Chang-Seok Ki; In-Suk Kim; Jong-Won Kim; Nam-Yong Lee; Sun Hee Kim; Kwang Woong 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Clinical significance of hepatitis C vir

Clinical significance of hepatitis C virus (HCV) infection in liver transplant recipients

✍ C. Lumbreras; R. Delgado; A. Fuertes; C. Loinaz; J. Iglesias; F. Colina; J. M. A 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 557 KB

Incidence and Management of Colorectal C

Incidence and Management of Colorectal Cancer in Liver Transplant Recipients

✍ Taiga Nishihori; Mario Strazzabosco; Muhammad Wasif Saif 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 104 KB

Effect of sirolimus on infection inciden

Effect of sirolimus on infection incidence in liver transplant recipients

✍ Adrian Fisher; Joseph M. Seguel; Andrew N. de la Torre; Dorian Wilson; Anand Mer 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

Sirolimus is a new immunosuppressive agent that lacks the nephrotoxicity and neurotoxicity associated with calcineurin inhibitors. [1][2][3] The addition of sirolimus to immunosuppressive protocols may thus allow sparing of calcineurin inhibitors and reduction or elimination of associated toxicities